These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 36309047)

  • 1. Efficacy of selective histone deacetylase 6 inhibition in mouse models of Pseudomonas aeruginosa infection: A new glimpse for reducing inflammation and infection in cystic fibrosis.
    Brindisi M; Barone S; Rossi A; Cassese E; Del Gaudio N; Feliz Morel ÁJ; Filocamo G; Alberico A; De Fino I; Gugliandolo D; Babaei M; Bove G; Croce M; Montesano C; Altucci L; Bragonzi A; Summa V
    Eur J Pharmacol; 2022 Dec; 936():175349. PubMed ID: 36309047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HDAC6 depletion improves cystic fibrosis mouse airway responses to bacterial challenge.
    Rosenjack J; Hodges CA; Darrah RJ; Kelley TJ
    Sci Rep; 2019 Jul; 9(1):10282. PubMed ID: 31311988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mouse models of chronic lung infection with Pseudomonas aeruginosa: models for the study of cystic fibrosis.
    Stotland PK; Radzioch D; Stevenson MM
    Pediatr Pulmonol; 2000 Nov; 30(5):413-24. PubMed ID: 11064433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of Rhesus Theta-Defensin-1 in Experimental Models of Pseudomonas aeruginosa Lung Infection and Inflammation.
    Bensman TJ; Jayne JG; Sun M; Kimura E; Meinert J; Wang JC; Schaal JB; Tran D; Rao AP; Akbari O; Selsted ME; Beringer PM
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chasing a Breath of Fresh Air in Cystic Fibrosis (CF): Therapeutic Potential of Selective HDAC6 Inhibitors to Tackle Multiple Pathways in CF Pathophysiology.
    Barone S; Cassese E; Alfano AI; Brindisi M; Summa V
    J Med Chem; 2022 Feb; 65(4):3080-3097. PubMed ID: 35148101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protease inhibitors elicit anti-inflammatory effects in CF mice with Pseudomonas aeruginosa acute lung infection.
    Sandri A; Lleo MM; Signoretto C; Boaretti M; Boschi F
    Clin Exp Immunol; 2021 Jan; 203(1):87-95. PubMed ID: 32946591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aerosolized bovine lactoferrin reduces neutrophils and pro-inflammatory cytokines in mouse models of Pseudomonas aeruginosa lung infections.
    Valenti P; Frioni A; Rossi A; Ranucci S; De Fino I; Cutone A; Rosa L; Bragonzi A; Berlutti F
    Biochem Cell Biol; 2017 Feb; 95(1):41-47. PubMed ID: 28129511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. β-sitosterol ameliorates inflammation and Pseudomonas aeruginosa lung infection in a mouse model.
    Rossi A; Bragonzi A; Medede M; De Fino I; Lippi G; Prosdocimi M; Tamanini A; Cabrini G; Dechecchi MC
    J Cyst Fibros; 2023 Jan; 22(1):156-160. PubMed ID: 35973900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen aggravates inflammation in Pseudomonas aeruginosa pneumonia in cystic fibrosis mice.
    Wang Y; Cela E; Gagnon S; Sweezey NB
    Respir Res; 2010 Nov; 11(1):166. PubMed ID: 21118573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resolvin D1 Reduces Lung Infection and Inflammation Activating Resolution in Cystic Fibrosis.
    Isopi E; Mattoscio D; Codagnone M; Mari VC; Lamolinara A; Patruno S; D'Aurora M; Cianci E; Nespoli A; Franchi S; Gatta V; Dubourdeau M; Moretti P; Di Sabatino M; Iezzi M; Romano M; Recchiuti A
    Front Immunol; 2020; 11():581. PubMed ID: 32528461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Harnessing Neutrophil Survival Mechanisms during Chronic Infection by
    Marteyn BS; Burgel PR; Meijer L; Witko-Sarsat V
    Front Cell Infect Microbiol; 2017; 7():243. PubMed ID: 28713772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of Pseudomonas aeruginosa secreted virulence factors reduces lung inflammation in CF mice.
    Sandri A; Ortombina A; Boschi F; Cremonini E; Boaretti M; Sorio C; Melotti P; Bergamini G; Lleo M
    Virulence; 2018; 9(1):1008-1018. PubMed ID: 29938577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic Pseudomonas aeruginosa infection in cystic fibrosis airway disease: metabolic changes that unravel novel drug targets.
    Yoon SS; Hassett DJ
    Expert Rev Anti Infect Ther; 2004 Aug; 2(4):611-23. PubMed ID: 15482224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microbial pathogenesis in cystic fibrosis: pulmonary clearance of mucoid Pseudomonas aeruginosa and inflammation in a mouse model of repeated respiratory challenge.
    Yu H; Hanes M; Chrisp CE; Boucher JC; Deretic V
    Infect Immun; 1998 Jan; 66(1):280-8. PubMed ID: 9423869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unveiling the modulation of
    Barone S; Mateu B; Turco L; Pelliccia S; Lembo F; Summa V; Buommino E; Brindisi M
    Front Microbiol; 2024; 15():1340585. PubMed ID: 38371939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-inflammatory action of lipid nanocarrier-delivered myriocin: therapeutic potential in cystic fibrosis.
    Caretti A; Bragonzi A; Facchini M; De Fino I; Riva C; Gasco P; Musicanti C; Casas J; Fabriàs G; Ghidoni R; Signorelli P
    Biochim Biophys Acta; 2014 Jan; 1840(1):586-94. PubMed ID: 24141140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of high-mobility group box 1 protein (HMGB1) enhances bacterial clearance and protects against Pseudomonas Aeruginosa pneumonia in cystic fibrosis.
    Entezari M; Weiss DJ; Sitapara R; Whittaker L; Wargo MJ; Li J; Wang H; Yang H; Sharma L; Phan BD; Javdan M; Chavan SS; Miller EJ; Tracey KJ; Mantell LL
    Mol Med; 2012 May; 18(1):477-85. PubMed ID: 22314397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA-G expression and regulation during Pseudomonas aeruginosa infection in cystic fibrosis patients.
    Rizzo R; Bergamini G; Bortolotti D; Leal T; D'Orazio C; Pintani E; Melchiorri L; Zavatti E; Assael BM; Sorio C; Melotti P
    Future Microbiol; 2016; 11(3):363-73. PubMed ID: 26934639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Azithromycin potentiates avian IgY effect against Pseudomonas aeruginosa in a murine pulmonary infection model.
    Thomsen K; Christophersen L; Lerche CJ; Holmgaard DB; Calum H; Høiby N; Moser C
    Int J Antimicrob Agents; 2021 Jan; 57(1):106213. PubMed ID: 33256950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Challenges with current inhaled treatments for chronic Pseudomonas aeruginosa infection in patients with cystic fibrosis.
    Greally P; Whitaker P; Peckham D
    Curr Med Res Opin; 2012 Jun; 28(6):1059-67. PubMed ID: 22401602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.